期刊文献+

2型糖尿病患者血清补体因子H与胰岛素抵抗相关性研究 被引量:4

Study of the Relationship between Insulin Resistance and Complement Factor H in Patients with Type 2 Diabetes Mellitus
下载PDF
导出
摘要 目的探讨体液循环中血清补体因子H的表达与糖脂代谢和胰岛素抵抗之间的相关性。方法将60例2型糖尿病患者按体质指数(BMI)分为肥胖组(BMI≥25 kg/m2)32例与非肥胖组(BMI﹤25 kg/m2)28例;30例同期健康体检正常者为对照组。采用酶联免疫吸附试验法检测血清补体因子H,放射免疫法测定胰岛素,全自动生化分析检测空腹血糖、血脂,全自动糖化分析仪测糖化血红蛋白(HbA1c);同时测量身高、体质量、血压、腰围、臀围、收缩压、舒张压,计算BMI和腰臀比(WHR),并计算胰岛素抵抗指数(HOMA-IR)。结果 3组受检者血清补体因子H比较,差异有统计学意义(P<0.05)。补体因子H水平与BMI、空腹血糖、HOMA-IR、HbA1c、空腹胰岛素、三酰甘油水平均呈正相关(P<0.01)。结论 2型糖尿病血清中补体因子H水平的升高,尤其是肥胖的2型糖尿病患者更明显,血清补体因子H可能参与了2型糖尿病肥胖患者的胰岛素抵抗的形成。2型糖尿病患者血清补体因子H水平均与胰岛素抵抗有关,表明在一定程度上,补体因子H水平可成为预测肥胖者发展为糖耐量异常的因子。 Objective To investigate the correlation between serum compliment factor H and glucolipid metabolism and insulin resistance in patients with type 2 diabetes.Methods 60 patients with type 2 diabetes were divided into obese group(BMI≥25 kg/m2,32 cases) and non-obese group(BMI25 kg/m2,28 cases) according to BMI.Meanwhile,30 healthy people were involved as control group.Serum complement factor H was determined by ELISA approach and the level of insulin was tested by radioimmunoassay.Fasting blood glucose and fasting blood lipid were tested by automatic biochemical analyzer and HbA1c was measured by automatic saccharification analyzer.Height,body weight,blood pressure,waist circumference,hip circumference,systolic pressure and diastolic pressure were tested at the same time to calculate BMI and WHR as well as HOMA-IR.Results The levels of serum complement factor H showed statistically significant differences between obese group,non-obese group and control group(P0.05).Correlation analysis showed that serum complement factor H was positively correlated with BMI,HOMA-IR,fasting blood glucose,HbA1c,fasting insulin and triglyceridemia(P0.05).Conclusion The levels of serum complement factor H were increased significantly in obese group compared with those in control group and non-obese group,and the serum complement factor H may be involved in the occurrence of insulin resistance in T2DM patients.Correlation analysis showed that serum complement factor H was positively correlated with BMI and HOMA-IR,indicating that it may predict the development from obesity to impaired glucose tolerance(IGT).
出处 《中国全科医学》 CAS CSCD 北大核心 2012年第14期1572-1574,共3页 Chinese General Practice
关键词 糖尿病 2型 胰岛素抵抗 补体因子H Diabetes mellitus type 2 Insulin resistance Complement factor H
  • 相关文献

参考文献9

  • 1Walport MJ. Complement : second of two parts [ J ]. N Engl J Med, 2001, 344 (15): 1140-1144. 被引量:1
  • 2Sjoberg AP, Trouw LA, Blom AM. Complement activation and inhibi- tion: a delicate balance [ J]. Trends Immunol, 2009, 30 (2): 83 -90. 被引量:1
  • 3Moreno - Navarrete JM, Martinez - Barricarte R, CatalOn V, et al. Complement factor H is expressed in adipose tissue in association with in- sulin resistance [J]. Diabete, 2010, 59 (1): 200-209. 被引量:1
  • 4Femandez - Real JM, Ricart W. Insulin resistance and chronic cardio- vascular inflammatory syndrome [ J ]. Endocr Rev, 2003, 24 ( 3 ) : 278 - 230. 被引量:1
  • 5Somani R, Grant PJ, Kain K. Complement C3 and C - reactive protein are elevated in South Asians independent of a family history of stroke [J]. Stroke, 2006, 37 (8): 2001-2006. 被引量:1
  • 6Schrauwen P, Hesselink MK, Jain M, et al. Acylation- stimulating protein: effect of acute exercise and endurance training [ J]. Int J Obes (Lond), 2005, 29 (6): 632-638. 被引量:1
  • 7Muscari A, Antonelli S, Bianchi G, et al. Serum C3 is a stronger in- flammmory marker of insulin resistance than C - reactive protein, leuko- cyte count, and erythrocyte sedimentation rate: comparison study in an elderly population [ J ]. Diabetes Care, 2007, 30 ( 9 ) : 2362 - 2368. 被引量:1
  • 8Paglialunga S, Fisette A, Yan Y, et al. Acylation - stimulating pro- tein deficiency and altered adipose tissue in alternative complement path- way knockout mice [J]. Am J Physiol Endocrinol Metab, 2008, 294 (3) : 521 -529. 被引量:1
  • 9Peake PW, Kriketos AD, Campbell LV, et al. Response of the alter- native complement pathway to an oral fat load in first - degree relatives of subjects with type II diabetes [ J ]. Int J Obes (Lond), 2005, 29 (4) : 429 -435. 被引量:1

同被引文献57

  • 1傅祖植.糖尿病·内科学[M].北京:人民卫生出版社,2004:787-814. 被引量:1
  • 2Gustafson B, Hedjazifar S, Gogg S, et al. Insulin resistance and impaired adipogenesis [ J ]. Trends Endocrinol Metab, 2015 ;26(4) : 193-200. 被引量:1
  • 3Imai C ,Harazaki T, Inoue S, et al. Treatment with dpp-4I anagliptin or α-GI miglitol reduces igt development and the expression of cvd risk factors in oletf rats [J].J Nutr Sci Vitaminol( Tokyo ) ,2015 ;61(4):313-321. 被引量:1
  • 4Phieler J, Garcia-martin R, Lambris JD, et al. The role of the complement system in metabolic organs and metabolic diseases [ J ]. Semin Immuno1,2013 ;25 ( 1 ) :47-53. 被引量:1
  • 5Van velsen EF, Lamers J, Blok V, et al A prospective study of concomitant glp-1 analogue and insulin use in type 2 diabetes in clinical practice [ J ]. Neth J Med, 2014;72:, (10) :523-527. 被引量:1
  • 6Markiewski MM, Lambris JD. The role of complement in inflammatory diseases from behind the scenes into the potlight [ J]. Am J Patho1,2007 ;171 ( 3 ) :715 -727. 被引量:1
  • 7Huber-lang M, Sarma JV, Zetoune FS, et al. Generation of C5a in the absence of C3:a new complement achvatlon pathway [ J ]. Nat Med,2006 ; 12 (6) :682-687. 被引量:1
  • 8Yang L, Chert SJ, Yuan GY, et al. Changes and clinical sig- nificance Of serum vaspin levels in patients with type 2 diabetes [ J ]. Genet Mol Res,2015 ; 14 ( 3 ) : 11356-11361. 被引量:1
  • 9Alamgir MA, Javid RA, Hameed A, et al.Gender difference in components of metabolic syndrome among patients of type 2 diabetes[ J]. Pak J Med Sci,2015 ;31(4) :886-890. 被引量:1
  • 10Wlazlo N, Van greevenbroek MM, Ferreira I, et al. Complement ftor 3 Is associated with insulin resistance and with incident type 2 diabetes mellitus over 7- year follow- up period : the eodam study [ J ]. Diabetes Care, 2014 ;37(7) : 1990-1999. 被引量:1

引证文献4

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部